Molecular Partners AG - ADR Forecast, price target & analysts
Molecular Partners AG - ADR Target price 2025 - Analyst rating & recommendation
Molecular Partners AG - ADR Classifications & Recommendation:
Molecular Partners AG - ADR Price Target
| Target Price | $13.30 |
| Price | $3.63 |
| Potential |
266.10%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Molecular Partners AG - ADR 2026 .
The average Molecular Partners AG - ADR target price is $13.30.
This is
266.10%
register free of charge
$19.56
438.38%
register free of charge
$7.53
107.15%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend Molecular Partners AG - ADR to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Molecular Partners AG - ADR stock has an average upside potential 2026 of
266.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 6.17 | 1.27 |
| 29.41% | 79.47% | |
| EBITDA Margin | -1,184.60% | -5,600.00% |
| 42.02% | 372.73% | |
| Net Margin | -1,088.01% | -5,492.14% |
| 23.51% | 404.79% |
4 Analysts have issued a sales forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Molecular Partners AG - ADR EBITDA forecast 2025. The average Molecular Partners AG - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Molecular Partners AG - ADR Analysts have issued a net profit forecast 2025. The average Molecular Partners AG - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.97 | -1.89 |
| 16.17% | 4.06% | |
| P/E | negative | |
| EV/Sales | 9.50 |
4 Analysts have issued a Molecular Partners AG - ADR forecast for earnings per share. The average Molecular Partners AG - ADR EPS is
This results in the following potential growth metrics and future valuations:
Molecular Partners AG - ADR...
Current Molecular Partners AG - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD COWEN |
Locked
➜
Locked
|
Locked | Aug 26 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Jun 13 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Jun 12 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD COWEN:
Locked
➜
Locked
|
Aug 26 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jun 13 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jun 12 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Mar 13 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Oct 31 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
